- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Nanomix Inc., a leading electronic detection company commercializing high-value diagnostic and monitoring applications, today announced an exclusive licensing agreement with MysticMD Inc., a provider of proprietary nano-coatings. Per this agreement, MysticMD will provide Nanomix with intellectual property related to the use of nano-ink for glucose test strip technology. This builds upon earlier work between the two organizations to optimize the technology and explore partnering opportunities.
David Macdonald, Nanomix CEO, said, "We are pleased to have partnered with MysticMD, and believe that our collaboration will create better performing glucose test strips at a lower cost."
Heidi Douglas, co-founder and CEO of MysticMD, said, "We are excited to be working with Nanomix, as they are uniquely positioned to make best use of this IP in product development. With Nanomix' expertise in the area of detection devices, we feel confident that this partnership will enable us to bring this technology to market quickly and effectively through broader collaborations with market leaders."
About Nanomix Inc.
Nanomix is a leading electronic detection company launching detection devices based on Sensation™ technology. These scaleable devices use ultra-sensitive carbon nanotube detection elements combined with proprietary chemistries. They can be deployed across high value respiratory and biomarker detection applications where low power consumption, small size, and ultra-sensitivity offer significant performance advantages and enable unprecedented access to critical information. For additional information, please visit www.nano.com.
MysticMD is an advanced materials company developing proprietary coating solutions using hybrid formulations of carbon nanotubes alloyed with traditional materials and other nano particles to solve real world problems. They are developing an intellectual property portfolio focused on dramatically improving their partners' products in key high value, high opportunity commercial applications. For more information, please visit http://www.mysticmd.com .
For more information, please click here
Copyright © MarketwireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
ATTOPSEMI Technology Joins FDXcelerator Program to Deliver Advanced Non-Volatile Memory IP to GLOBALFOUNDRIES 22 FDX® Technology Platform: Leading-edge I-fuse™ brings higher reliability, smaller cell size and ease of programmability for consumer, automotive, and IoT applications March 27th, 2017
Leti and HORIBA Scientific to Host Webinar on Ultrafast Characterization Tool: Plasma Profiling Time-of-Flight Mass Spectrometer Tool Cuts Optimization Time In Layer Deposition and Fabrication of Wide Range of Applications March 27th, 2017
Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017
Intertronics introduce new nanoparticle deagglomeration technology March 15th, 2017